MPO and Alzheimer disease: A handful of studies have reported a link between polymorphism in myeloperoxidase and AD risk [52,[57], [58], [59], [60], [61]], however, a similar number of studies have not found an association [[62], [63], [64], [65]], nor has a genetic link been identified between myeloperoxidase and AD in genome-wide association studies.